J Mov Disord.
2024 Apr;17(2):233-235. 10.14802/jmd.23265.
Meige Syndrome as a Craniofacial Type of Dystonia Treatable by Dual Dopaminergic Modulation Using L-DOPA/Chlorpromazine: A Case Report
- Affiliations
-
- 1Department of Neurology, Osaka Neurological Institute, Osaka, Japan
- 2Center for Drug Discovery and Development Sciences, Research Organization of Science and Technology, Ritsumeikan University, Kyoto, Japan
- 3Department of Clinical Neuroscience, Institute of Biomedical Sciences, Tokushima University, Tokushima, Japan
- KMID: 2554702
- DOI: http://doi.org/10.14802/jmd.23265
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- A Case of Meige's Syndrome: Differential Diagnosis from Conversion Disorder
- Three Cases of Meige's Syndrome (Blepharospasm-Orofacial Dystonia Syndrome)
- Dopa-responsive dystonia: a syndrome of selective nigrostriatal dopaminergic deficiency
- A Clinical Study of 11 Patients with Meige's Syndrome
- Sulpiride in Meige's Syndrome: Possible Role of Glutamate
